Compare BCBP & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BCBP | PRE |
|---|---|---|
| Founded | 2000 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 137.8M | 131.3M |
| IPO Year | N/A | N/A |
| Metric | BCBP | PRE |
|---|---|---|
| Price | $8.38 | $14.64 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 1 |
| Target Price | $9.25 | ★ $32.00 |
| AVG Volume (30 Days) | 87.8K | ★ 137.5K |
| Earning Date | 01-27-2026 | 11-10-2025 |
| Dividend Yield | ★ 7.63% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | $64,592,000.00 | ★ $77,079,000.00 |
| Revenue This Year | $23.06 | $219.28 |
| Revenue Next Year | $3.55 | $124.38 |
| P/E Ratio | $168.57 | ★ N/A |
| Revenue Growth | N/A | ★ 201.54 |
| 52 Week Low | $7.41 | $3.10 |
| 52 Week High | $13.17 | $17.99 |
| Indicator | BCBP | PRE |
|---|---|---|
| Relative Strength Index (RSI) | 62.80 | 53.29 |
| Support Level | $7.85 | $12.93 |
| Resistance Level | $8.50 | $15.70 |
| Average True Range (ATR) | 0.16 | 1.12 |
| MACD | 0.06 | 0.07 |
| Stochastic Oscillator | 82.49 | 56.68 |
BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection and automated teller services.
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.